Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/1999
12/09/1999WO1999063098A1 Recombinant venezuelan equine encephalitis virus vaccine
12/09/1999WO1999063095A1 Nucleic acid vaccines for prevention of flavivirus infection
12/09/1999WO1999063093A2 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
12/09/1999WO1999062910A1 Process for preparing crystalline salts of amoxycillin
12/09/1999WO1999062907A1 Fused phenoxymethyl carbapenem antibacterials
12/09/1999WO1999062906A1 Benzothiazolythiomethyl carbapenem antibacterial
12/09/1999WO1999062904A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
12/09/1999WO1999062897A1 Hiv integrase inhibitors
12/09/1999WO1999062878A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
12/09/1999WO1999062875A1 Nitric oxide synthase inhibitors
12/09/1999WO1999062546A1 Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants
12/09/1999WO1999062542A1 Recombinant human interferon beta-1a (ifn-beta-1a) formulation
12/09/1999WO1999062538A1 Alpha-keto oxadiazoles as serine protease inhibitors
12/09/1999WO1999062534A1 IL-6/sIL-6R COMPLEX FOR PROMOTION OF LIVER FUNCTIONS
12/09/1999WO1999062504A2 Topical administration of oxazolidinones for transdermal delivery
12/09/1999WO1999062500A1 Stabilizers for lyophilized vaccines
12/09/1999WO1999062498A1 Spill resistant pharmaceutical compositions
12/09/1999WO1999062451A1 Topical transdermal treatments
12/09/1999WO1999051617A3 FORM VI 5,6-DICHLORO-2-(ISOPROPYLAMINO)-1-(β-L-RIBOFURANOSYL)-1H-BENZIMIDAZOLE
12/09/1999WO1999051266A3 Derivatives of pneumococcal choline binding proteins for vaccines
12/09/1999WO1999049885A3 The use of isolated domains of type iv collagen to modify cell and tissue interactions
12/09/1999WO1999048917A3 Formulation having a papilloma virus-specific protein, and the production and use thereof
12/09/1999WO1999047507A3 1,3,4-thiadiazoles useful for the treatment of cmv infections
12/09/1999WO1999042466A3 β-LACTAM-LIKE CHAPERONE INHIBITORS
12/09/1999DE19808962A1 Wirkstoffkombinationen und Desinfektionsmittel, Konservierungsmittel und Antiseptika dieselben enthaltend Active compound combinations and disinfectants, antiseptics and preservatives containing the same
12/09/1999CA2333994A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
12/09/1999CA2333943A1 Process for preparing crystalline salts of amoxycillin
12/09/1999CA2333903A1 Topical transdermal treatments
12/09/1999CA2333771A1 Hiv integrase inhibitors
12/09/1999CA2333658A1 Fused phenoxymethyl carbapenem antibacterials
12/09/1999CA2333621A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
12/09/1999CA2333620A1 Benzothiazolythiomethyl carbapenem antibacterial
12/09/1999CA2333505A1 Stabilizers for lyophilized vaccines
12/09/1999CA2333063A1 Recombinant human interferon beta-1a (ifn-beta-1a) formulation
12/09/1999CA2331196A1 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
12/09/1999CA2329512A1 Il-6/sil-6r complex for promotion of liver functions
12/09/1999CA2327326A1 Topical administration of oxazolidinones for transdermal delivery
12/08/1999EP0962463A1 Uncharged morpholino-based polymers having phosphorus-containing chiral intersubunit linkages
12/08/1999EP0961793A1 Polymers incorporating peptides
12/08/1999EP0961779A1 SUBSTITUTED AMINO BICYCLIC-$g(b)-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS
12/08/1999EP0961778A1 3-hydroxyacyl-coa dehydrogenase from staphylococcus aureus
12/08/1999EP0961776A1 Tricyclic erythromycin derivatives
12/08/1999EP0961775A2 Purine l-nucleosides, analogs and uses thereof
12/08/1999EP0961615A1 Antimicrobial agent
12/08/1999EP0775158B1 Cyclopeptolides
12/08/1999EP0730587B1 3-phenyl-2-isoxazolines as antiinflammatory agents
12/08/1999EP0702565B1 Helicobacter pylori catalase-based immunising composition
12/08/1999EP0659177B1 4-oxo-azetidine-2-sulphonic acid amides and their salts, process for their production and their use
12/08/1999EP0634934B1 Use of dietary whey proteins for the treatment of hiv-seropositive individuals
12/08/1999EP0600970B1 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity
12/08/1999CN1237910A Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and use of anti-lymphotoxin ligand antibodies
12/08/1999CN1237456A Epidemic hemorrhagic fever passage cell polyvalent purified vaccine
12/08/1999CN1237451A Enema liquor for woman pelvic inflammation
12/08/1999CN1237437A Chinese medicine composition for producing domestic chemical product
12/07/1999US5998605 Antiviral benzimidazole nucleoside analogues and method for their preparation
12/07/1999US5998602 RNase L activators and antisense oligonucleotides effective to treat RSV infections
12/07/1999US5998601 VR-2332 viral nucleotide sequence and methods of use
12/07/1999US5998587 Anti-cyanovirin antibody
12/07/1999US5998583 BH3 interacting domain death agonist
12/07/1999US5998581 Reductive alkylation of glycopeptide antibiotics
12/07/1999US5998472 Enhanced flexibility of polymeric film on mammalian skin
12/07/1999US5998469 Nervous system diosrders; autoimmune diseases; antiinflammatory agents
12/07/1999US5998436 Pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising the same as the active ingredient
12/07/1999US5998413 Fungicide
12/07/1999US5998411 Viricides
12/07/1999US5998406 Bactericides
12/07/1999US5998398 2-amino-5,6-dichlorobenzimidazole derivatives having antiviral activity
12/07/1999US5998390 Combination of bisphosphonate and tetracycline
12/07/1999US5998193 Genetic engineering
12/07/1999US5998169 Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus
12/07/1999US5997943 Compound for a non-wettable coating, process for treatment of glass with the aid of the compound and products obtained
12/07/1999US5997882 Epitopic regions of pneumococcal surface protein A
12/07/1999US5997881 Method of making non-pyrogenic lipopolysaccharide or A
12/07/1999US5997880 Method for alleviating varicella related post-herpetic neuralgia
12/07/1999US5997878 Recombinant poxvirus-cytomegalovirus, compositions and uses
12/07/1999US5997867 Method of using humanized antibody against CD18
12/07/1999US5997862 Therapeutic treatment of group A streptococcal infections
12/07/1999US5997861 Antiviral supramolecules containing target-binding molecules and therapeutic molecules bound to spectrin
12/07/1999CA2198231C Dihydropyridine derivatives as bradykinin antagonists
12/07/1999CA2157410C Enhanced circulation effector composition and method
12/07/1999CA2116764C Immunoreactive hepatitis c virus polypeptide compositions
12/07/1999CA2073288C Manipulation of gene copy number in bordetella
12/07/1999CA2020663C Substitution analogues of magainin peptides
12/07/1999CA2004991C Deletion analogues of magainin peptides
12/07/1999CA1340841C Cecropin-like polypeptides with activity against gram-positive and gram-negative bacteria
12/07/1999CA1340838C Coccidiosis vacine
12/02/1999WO1999061918A1 Method and means for caries prevention and susceptibility detection
12/02/1999WO1999061916A1 Identification of broadly reactive dr restricted epitopes
12/02/1999WO1999061620A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
12/02/1999WO1999061614A2 Human socs proteins
12/02/1999WO1999061613A2 Interference with viral ires-mediated translation by a small yeast rna reveals critical rna-protein interactions
12/02/1999WO1999061608A2 Polypeptides from creb binding protein and related protein p300 for use in transcriptional regulation
12/02/1999WO1999061593A1 USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES
12/02/1999WO1999061476A1 Peptide antiangiogenic drugs
12/02/1999WO1999061473A1 Method for purification of borrelia lipoprotein ospa
12/02/1999WO1999061471A2 Human transmembrane proteins
12/02/1999WO1999061470A1 Respiratory nitrate reductase alpha subunit
12/02/1999WO1999061468A2 The induction of antibiotic peptides by lait (scd14) protein
12/02/1999WO1999061453A2 priA
12/02/1999WO1999061452A2 acpS
1 ... 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 ... 1798